How to prepare for the next inevitable Ebola outbreak: lessons from West Africa
By Dr. Mosoka Fallah (co-author) in Nature Medicine
Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe: a scoping review
By Dr. Veronika Wirtz (co-author) in BMJ Global Health
Host Response Markers of Inflammation and Endothelial Activation Associated with COVID-19 Severity and Mortality: A GeoSentinel Prospective Observational Cohort
by Dr. David Hamer (co-author) in Viruses
Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns
by Dr. Laura White (co-author) in BMC Infectious Diseases
The time to address the antibiotic pipeline and access crisis is now
by Kevin Outterson (co-author) in The Lancet
Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa
By Dr. Mosoka Fallah (co-author) in BMJ Global Health
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study
By Dr. Jai Marathe (co-author) in Clinical Microbiology and Infection
Outcomes of Severe M-POX Admitted to Intensive Care Units At Two Large New York City Health Systems, 2022-2024: A Case Series
by Dr. Madeline DiLorenzo (co-author) in Disaster Medicine
Institutional Readiness to Provide Critical Care to Patients with Viral Hemorrhagic Fever After the COVID-19 Pandemic
by Dr. Madeline DiLorenzo (co-author) in Disaster Medicine
Safety and immunogenicity of a delayed booster dose of the rVSVĪG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
By Dr. Nahid Bhadelia (co-author) in The Lancet Microbe